Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003;112(1-2):37-41.
doi: 10.1016/j.thromres.2003.11.007.

Blood levels of homocysteine, folate, vitamin B6 and B12 in women using oral contraceptives compared to non-users

Federico Lussana  1 , Maddalena L Zighetti, Paolo Bucciarelli, Massimo Cugno, Marco Cattaneo
Affiliations
Clinical Trial

Blood levels of homocysteine, folate, vitamin B6 and B12 in women using oral contraceptives compared to non-users

Federico Lussana et al. Thromb Res. 2003.

Abstract

Background and objectives: To compare the levels of total homocysteine (tHcy), folate, vitamin B6 and B12, in women not using oral contraceptives (OC) vs. those using OC.

Materials and methods: 219 healthy women were enrolled in the study; 159 of them had not been using OC for at least 12 months prior to their enrollment, while 60 were on regular OC treatment.

Results: The median levels of vitamin B6 and B12 were significantly lower in OC users than in non-users (24.2 vs. 32.9 nmol/l, p=0.029; 278 vs. 429 ng/ml, p<0.001). There were no statistically significant differences in the levels of tHcy (fasting and post-methionine loading) and folate.

Conclusions: In our cross-sectional study, OC use was associated with low vitamin B6 and B12 levels. Since low vitamin B6 levels are independently associated with heightened risks for arterial and venous thromboembolism (TE), they could partly account for the increased TE risk of OC users.

PubMed Disclaimer

LinkOut - more resources